Stay updated on HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Sign up to get notified when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The study record was updated to standardize the Intervention/Treatment heading, add the investigator name Xuexin He and last-verified status, and include new help sections (How to Read a Study Record, Common Questions, How to Join a Study) with a revision tag Revision: v3.6.0. Removed the older items 'Intervention / Treatment', the full investigator attribution ('xuexin he, Second Affiliated Hospital, School of Medicine, Zhejiang University'), and the previous revision tag (Revision: v3.5.5).
    Difference
    1%
    Check dated 2026-06-12T23:32:44.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.5.5, replacing the previous v3.5.4. This indicates a minor backend or UI update rather than a change to study details.
    Difference
    0.0%
    Check dated 2026-06-05T18:20:19.000Z thumbnail image
  4. Check
    42 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, indicating a small release of the site software; no study data or visible content changes are introduced.
    Difference
    0.0%
    Check dated 2026-05-15T06:23:04.000Z thumbnail image
  5. Check
    49 days ago
    Change Detected
    Summary
    A Last known status entry was added, listing the investigator and affiliation with a date and verification status. This update adds metadata about who last verified the record and when.
    Difference
    0.4%
    Check dated 2026-05-08T09:19:04.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    The page’s display/release revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change without affecting the study information content.
    Difference
    0.1%
    Check dated 2026-04-24T04:28:07.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-16T21:36:25.000Z thumbnail image

Stay in the know with updates to HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the HER2 Therapy+Fulvestrant/Capecitabine in HR+/HER2+ MBC Clinical Trial page.